Veri MedTech's IPO

Q: When is Veri MedTech's IPO?

3,750,000 shares at $4 (amended S-1 of Sep 22, 2026). No day set yet.

Q: What is Veri MedTech's IPO price?

Veri MedTech set a price of $4 a share in its amended S-1 of Sep 22, 2026. The final price is set the evening before it lists.

Q: How many shares is Veri MedTech selling?

3,750,000 shares, per its amended S-1.

Q: When does the lock-up end?

Its prospectus sets a lock-up of 180 days; the day it ends is read from its final prospectus once it lists.

3,750,000 shares at $4 (amended S-⁠1 of Sep 22, 2026). No day set yet.

Range

3,750,000

Ticker

VRHI

Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.

Once Veri MedTech lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day VRHI lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

From its amended S-1 on SEC EDGAR, filed Sep 22, 2026.

What does Veri MedTech do?

“We are an "emerging growth company" as defined in the Jumpstart Our Business Startups Act (the "JOBS Act").”

From its amended S-1, filed Sep 22, 2026

Veri MedTech's facts, each with its source
Fact	Veri MedTech
Founded	2017From its amended S-1 of Sep 22, 2026
Headquarters	McLean, VirginiaFrom its amended S-1 of Sep 22, 2026
Website	verimedtech.comFrom its amended S-1 of Sep 22, 2026

What is the offering?

Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.

Veri MedTech's facts, each with its source
Fact	Veri MedTech
Shares offered	3,750,000From the amended S-1 filed Sep 22, 2026
Proposed price	$4 a shareFrom the amended S-1 filed Sep 22, 2026
Net proceeds the company expects	About $11.9 millionFrom the amended S-1 filed Sep 22, 2026
Underwriters	N E T W O R K 1 F I N A N C I A L and S E C U R I T I E S, I N CFrom the amended S-1 filed Sep 22, 2026, as its cover names them
Exchange	Nasdaq Capital Market, as VRHI (applied to list)From the amended S-1 filed Sep 22, 2026

What the filing says about its money

Veri MedTech's facts, each with its source
Fact	Veri MedTech
Net loss	$2.3 million, year to December 31, 2025From its amended S-1 of Sep 22, 2026, its summary financial data
Last preferred stock	Series A preferredFrom its amended S-1 of Sep 22, 2026

What risks does Veri MedTech name first?

“Our limited operating history makes it difficult to evaluate our current business and future prospects, and our recent success may not be indicative of our future results of operations.”
“Our business and operations have experienced periods of rapid growth, and if we do not appropriately manage future growth, if any, or are unable to improve our systems and processes, our business, financial condition and results of operations will be adversely affected.”
“If we are unable to attract new clients or continue to broaden our existing clients' use of our solutions, our business, financial condition and results of operations could be materially and adversely affected.”

The first three of the risks its prospectus summary lists, in the company's words. The rest, and each in full, are in the filing. Read the filing.

Every date of Veri MedTech's IPO

Veri MedTech's IPO dates, each with its source
What	Day	Source
Registration filedForm S-1, SEC EDGAR	Nov 14, 2025	Form S-1, SEC EDGAR
Price setamended S-1, SEC EDGAR	Sep 22, 2026	amended S-1, SEC EDGAR
Lock-upPer its amended S-1; the day comes once it lists	180 days	Per its amended S-1; the day comes once it lists

The other IPOs expected

The other IPOs expected or in registration
Company	Price	Market cap	Expected
OPAYNYSE: OPAY · No day yet	$19 to $21	Not yet	No day yetexchange registration Oct 26
Georgia BankingNasdaq: GBC · No day yet	Direct	Not yet	No day yetexchange registration Oct 21
Aspen NeuroscienceNasdaq: ASPE · No day yet	$15 to $17About $465M	$465Mat the midpoint	No day yetterms set Oct 26
Bambusa TherapeuticsNasdaq: BBTX · No day yet	$15 to $17About $796M	$796Mat the midpoint	No day yetterms set Oct 26
BitariNasdaq: BIAI · No day yet	$7About $302M	$302Mat the midpoint	No day yetterms set Oct 26
LIS TechnologiesNasdaq · No day yet	$5 to $7	Not yet	No day yetterms set Oct 26

Veri MedTech IPO questions

When is Veri MedTech's IPO?

3,750,000 shares at $4 (amended S-⁠1 of Sep 22, 2026). No day set yet.

What is Veri MedTech's IPO price?

Veri MedTech set a price of $4 a share in its amended S-⁠1 of Sep 22, 2026. The final price is set the evening before it lists.

How many shares is Veri MedTech selling?

3,750,000 shares, per its amended S-⁠1.

Who are the underwriters?

N E T W O R K 1 F I N A N C I A L and S E C U R I T I E S, I N C, as the prospectus's cover names them.

When does the lock-up end?

Its prospectus sets a lock-⁠up of 180 days; the day it ends is read from its final prospectus once it lists.

Does Breakaway rate Veri MedTech?

Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.

Can Breakaway say where Veri MedTech's price will go?

No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.

Where every figure comes from.

Each company's SEC filings on EDGAR, read twice a day: its registration (Form S-1 or F-1), the amendment that sets its price range, and its final prospectus (424B4). The shares, the price, the underwriters, the lock-up, and the company's words are the filing's, linked on each line.
The expected day is Massive's IPO calendar's, the first trade the market data's, and the moves each stock's daily closes against its offer price.
The market cap is Breakaway's arithmetic: the shares the prospectus says will be outstanding after the offering, times the midpoint of the range or the offer price.
The Quality Score is Breakaway's, from a stock's second trading day; for its first 21 sessions it is marked New listing, and each check that needs more history waits for it.
Blank-check companies (SPACs) and unit offerings are left out and counted; a direct listing and a US listing of a company listed abroad are in and marked.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Once Veri MedTech lists, Breakaway scores it against every US stock

Its Quality Score from its second session, ranked against 3,191 stocks
Every insider trade, the day it is filed
The lock-up's end on your calendar, once the prospectus dates it
An alert when its score is first set, and when it turns

Get an alert the day VRHI lists

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Every IPO expected and listed.